Early Muscle Loss in PICU Predicts Poor Outcomes in Children, Suggests Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2026-05-05 15:15 GMT | Update On 2026-05-05 15:16 GMT
Advertisement
China: Children admitted to the pediatric intensive care unit (PICU) develop progressive muscle wasting within the first week. Greater loss of muscle mass is linked to worse clinical outcomes, and the reduction in rectus femoris cross-sectional area (RF CSA) by day 5 can predict in-hospital mortality. Ultrasound assessment serves as a useful tool to identify high-risk patients early.
A new prospective observational study published in the European Journal of Pediatrics further strengthens this association, highlighting the prognostic value of early muscle loss in critically ill, mechanically ventilated children. The research, led by Ye Cai from the Children’s Hospital of Chongqing Medical University, examined how changes in peripheral muscle mass relate to survival outcomes in the pediatric intensive care setting.
The study enrolled 86 children aged between one month and under 18 years who required mechanical ventilation for at least 48 hours. Using bedside ultrasound, investigators measured muscle thickness and cross-sectional area of the biceps brachii and rectus femoris within 24 hours of admission and subsequently on days 3, 5, and 7. This serial assessment allowed the team to track the progression of muscle wasting during the early phase of critical illness.
The following were the key findings:
- Muscle mass showed a continuous decline during the first week of PICU admission.
- Both the biceps brachii and the rectus femoris muscles progressively decreased in size.
- The observed muscle loss reflects a rapid catabolic state in critically ill children.
- The degree of muscle loss differed significantly between survivors and non-survivors.
- Non-survivors had greater reductions in rectus femoris cross-sectional area on days 3, 5, and 7.
- A more pronounced decline in biceps brachii cross-sectional area was seen by day 3 in non-survivors.
- Loss of rectus femoris muscle mass by day 5 was the strongest predictor of mortality.
- A reduction of ≥17.62% in rectus femoris cross-sectional area by day 5 was linked to a higher risk of in-hospital death.
- This cutoff showed good predictive accuracy with balanced sensitivity and specificity.
- Children with less muscle loss than this threshold had a significantly lower risk of mortality, even after adjustment for other factors.
These findings highlight the value of early, dynamic muscle monitoring in critically ill children. Bedside ultrasound provides a simple, non-invasive way to track muscle loss in real time, helping clinicians identify high-risk patients and guide timely interventions.
The study reinforces that muscle wasting is not just a consequence of critical illness but also an important prognostic marker, offering insights into disease severity and recovery potential.
The researchers concluded that early loss of the rectus femoris muscle is a strong predictor of in-hospital mortality, and routine ultrasound assessment in the PICU could improve risk stratification and clinical decision-making.
Reference:
Cai, Y., Zhang, Q., Meng, Y. et al. Association of peripheral muscle mass and in-hospital mortality in mechanically ventilated critically ill children: a prospective observational study. Eur J Pediatr 185, 236 (2026). https://doi.org/10.1007/s00431-026-06799-5
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.